See more : GameOn Entertainment Technologies Inc. (GMETF) Income Statement Analysis – Financial Results
Complete financial analysis of Toho Holdings Co., Ltd. (8129.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Toho Holdings Co., Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Chitradurga Spintex Limited (CHITRTX.BO) Income Statement Analysis – Financial Results
- Johnson Controls-Hitachi Air Conditioning India Limited (JCHAC.BO) Income Statement Analysis – Financial Results
- Vidler Water Resources, Inc. (VWTR) Income Statement Analysis – Financial Results
- Unima 2000 Systemy Teleinformatyczne S.A. (U2K.WA) Income Statement Analysis – Financial Results
- Ober SA (ALOBR.PA) Income Statement Analysis – Financial Results
Toho Holdings Co., Ltd. (8129.T)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.tohohd.co.jp
About Toho Holdings Co., Ltd.
Toho Holdings Co., Ltd. engages in the wholesale distribution of pharmaceutical products in Japan. It sells prescription pharmaceuticals, reagents, medical devices and materials, OTC drugs, health foods, preventive care, clinical care, community healthcare linkage, and home medical and nursing care, as well as provides support services, including the development and sale of customer support systems, assistance in the start-up of medical institutions and pharmacies, management consulting services, medical support, and personnel recruitment. The company also engages in dispensing pharmacy business; manufacture and sale of generic drugs; and site management organization business that assists various medical institutions with clinical trials under contract, as well as sells software to medical institutions. In addition, it provides various customer support systems, including ENIF, an information terminal for pharmaceutical ordering; ENI-Pharmacy, a support system for the separation of dispensing and prescribing functions; LXMATE HeLios a medical care appointment system; KAITOS, an online medical consultation and medication guidance system; ENIFwin, an inventory control system for large hospitals; ENIFvoice SP/ ENIFvoice SP + A/ ENIFvoice Core, a supporting system for electronic medication history recording with voice recognition; and ENIF Nurse, an operation support terminal for home-visit nurses; and logistics systems. The company was incorporated in 1948 and is headquartered in Tokyo, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,476.71B | 1,388.57B | 1,266.17B | 1,210.33B | 1,263.77B | 1,222.20B | 1,213.32B | 1,231.18B | 1,308.36B | 1,162.11B | 1,189.62B | 1,140.36B | 1,108.14B | 1,059.58B | 1,002.11B | 838.95B | 805.41B | 773.44B | 706.49B | 603.59B |
| Cost of Revenue | 1,357.56B | 1,277.75B | 1,157.48B | 1,110.96B | 1,148.35B | 1,110.15B | 1,099.15B | 1,121.18B | 1,182.43B | 1,055.79B | 1,084.52B | 1,038.36B | 1,010.89B | 973.44B | 920.69B | 776.61B | 739.49B | 709.81B | 654.57B | 559.60B |
| Gross Profit | 119.15B | 110.82B | 108.69B | 99.37B | 115.42B | 112.04B | 114.17B | 109.99B | 125.93B | 106.32B | 105.10B | 102.00B | 97.26B | 86.15B | 81.43B | 62.34B | 65.93B | 63.63B | 51.92B | 43.99B |
| Gross Profit Ratio | 8.07% | 7.98% | 8.58% | 8.21% | 9.13% | 9.17% | 9.41% | 8.93% | 9.62% | 9.15% | 8.84% | 8.94% | 8.78% | 8.13% | 8.13% | 7.43% | 8.19% | 8.23% | 7.35% | 7.29% |
| Research & Development | 445.00M | 355.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.02B | 1.07B | 1.07B | 923.00M | 1.08B | 1.17B | 1.11B | 1.10B | 1.21B | 1.50B | 1.58B | 1.52B | 48.56B | 46.97B | 40.99B | 34.49B | 32.47B | 4.42B | 27.75B | 24.83B |
| Selling & Marketing | 89.98B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 90.99B | 1.07B | 1.07B | 923.00M | 1.08B | 1.17B | 1.11B | 1.10B | 1.21B | 1.50B | 1.58B | 1.52B | 48.56B | 46.97B | 40.99B | 34.49B | 32.47B | 4.42B | 27.75B | 24.83B |
| Other Expenses | 8.38B | 5.07B | 4.30B | 4.80B | 4.64B | 4.20B | 4.35B | 4.35B | 4.75B | 4.33B | 4.43B | 1.94B | 3.97B | 3.93B | 3.39B | 3.42B | 3.50B | 3.66B | 2.97B | 2.61B |
| Operating Expenses | 99.82B | 98.00B | 96.15B | 95.06B | 97.82B | 96.25B | 95.15B | 95.74B | 97.30B | 96.47B | 92.77B | 86.11B | 68.83B | 66.76B | 58.03B | 48.09B | 45.17B | 44.25B | 45.86B | 40.59B |
| Cost & Expenses | 1,457.38B | 1,375.75B | 1,253.64B | 1,206.02B | 1,246.18B | 1,206.41B | 1,194.30B | 1,216.93B | 1,279.73B | 1,152.26B | 1,177.29B | 1,124.47B | 1,079.72B | 1,040.19B | 978.72B | 824.70B | 784.65B | 754.06B | 700.43B | 600.19B |
| Interest Income | 58.00M | 58.00M | 64.00M | 75.00M | 83.00M | 94.00M | 70.00M | 75.00M | 85.00M | 76.00M | 95.00M | 142.00M | 154.00M | 174.00M | 124.00M | 141.00M | 137.00M | 95.00M | 59.00M | 56.00M |
| Interest Expense | 145.00M | 72.00M | 76.00M | 79.00M | 30.00M | 30.00M | 50.00M | 91.00M | 199.00M | 324.00M | 410.00M | 387.00M | 519.00M | 586.00M | 401.00M | 132.00M | 103.00M | 91.00M | 165.00M | 183.00M |
| Depreciation & Amortization | 6.51B | 6.41B | 6.96B | 6.80B | 5.84B | 6.44B | 6.46B | 6.67B | 7.30B | 7.27B | 6.10B | 5.32B | 3.64B | 3.35B | 2.88B | 2.32B | 1.77B | 1.67B | 1.06B | 931.00M |
| EBITDA | 37.44B | 19.23B | 19.49B | 10.86B | 30.12B | 27.39B | 29.70B | 28.63B | 42.61B | 29.09B | 24.42B | 25.31B | 24.69B | 12.99B | 18.67B | 1.74B | 15.63B | 13.56B | 8.29B | 6.88B |
| EBITDA Ratio | 2.54% | 1.85% | 2.00% | 1.44% | 2.34% | 2.28% | 2.60% | 2.16% | 3.21% | 1.98% | 2.02% | 2.14% | 3.38% | 2.69% | 3.14% | 1.88% | 3.41% | 3.38% | 1.56% | 1.30% |
| Operating Income | 19.33B | 12.81B | 12.53B | 4.30B | 17.59B | 15.78B | 19.02B | 14.24B | 28.62B | 10.02B | 12.33B | 15.88B | 14.07B | 5.84B | 10.94B | 3.02B | 10.27B | 9.34B | 6.06B | 3.40B |
| Operating Income Ratio | 1.31% | 0.92% | 0.99% | 0.36% | 1.39% | 1.29% | 1.57% | 1.16% | 2.19% | 0.86% | 1.04% | 1.39% | 1.27% | 0.55% | 1.09% | 0.36% | 1.27% | 1.21% | 0.86% | 0.56% |
| Total Other Income/Expenses | 11.45B | 7.61B | 7.58B | 5.97B | 6.66B | 5.13B | 4.18B | 7.63B | 6.50B | 11.47B | 5.58B | 3.73B | 4.93B | 1.64B | 2.85B | -3.74B | 3.49B | 2.46B | 957.00M | 2.37B |
| Income Before Tax | 30.78B | 20.42B | 20.11B | 10.27B | 24.25B | 20.91B | 23.20B | 21.87B | 35.11B | 21.49B | 17.91B | 19.61B | 19.00B | 7.48B | 13.78B | -715.00M | 13.76B | 11.80B | 7.06B | 5.77B |
| Income Before Tax Ratio | 2.08% | 1.47% | 1.59% | 0.85% | 1.92% | 1.71% | 1.91% | 1.78% | 2.68% | 1.85% | 1.51% | 1.72% | 1.71% | 0.71% | 1.38% | -0.09% | 1.71% | 1.53% | 1.00% | 0.96% |
| Income Tax Expense | 10.11B | 6.77B | 6.70B | 5.28B | 8.02B | 7.05B | 8.81B | 7.65B | 13.34B | 7.95B | 7.50B | 8.08B | 8.23B | 231.00M | 5.54B | 1.71B | 4.80B | 4.46B | 3.23B | 2.14B |
| Net Income | 20.66B | 13.63B | 13.38B | 4.99B | 16.23B | 13.86B | 14.38B | 14.23B | 21.77B | 13.54B | 10.41B | 11.53B | 10.77B | 7.28B | 8.26B | -2.47B | 8.38B | 7.22B | 3.61B | 3.41B |
| Net Income Ratio | 1.40% | 0.98% | 1.06% | 0.41% | 1.28% | 1.13% | 1.19% | 1.16% | 1.66% | 1.16% | 0.87% | 1.01% | 0.97% | 0.69% | 0.82% | -0.29% | 1.04% | 0.93% | 0.51% | 0.56% |
| EPS | 320.14 | 196.69 | 189.69 | 70.76 | 233.34 | 177.78 | 190.60 | 207.12 | 316.51 | 181.83 | 139.58 | 159.21 | 142.24 | 97.83 | 125.69 | -41.72 | 148.23 | 125.82 | 72.26 | 72.75 |
| EPS Diluted | 286.79 | 180.67 | 174.48 | 64.97 | 208.55 | 177.78 | 190.60 | 188.22 | 287.93 | 177.74 | 139.54 | 159.21 | 142.24 | 97.83 | 122.83 | -41.72 | 135.55 | 115.10 | 65.02 | 72.75 |
| Weighted Avg Shares Out | 64.52M | 69.30M | 70.53M | 70.51M | 69.55M | 77.98M | 75.47M | 68.68M | 68.79M | 74.44M | 74.56M | 72.40M | 75.69M | 74.45M | 65.75M | 59.23M | 56.55M | 57.40M | 49.50M | 46.35M |
| Weighted Avg Shares Out (Dil) | 72.03M | 75.37M | 76.60M | 76.59M | 77.74M | 77.98M | 75.47M | 75.58M | 75.61M | 76.15M | 74.58M | 72.40M | 75.69M | 74.45M | 67.27M | 59.23M | 61.83M | 62.71M | 55.55M | 46.35M |
Source: https://incomestatements.info
Category: Stock Reports